Scarica l'app Stockscreener
7.82
4.28%
-0.35
Dopo l'orario di chiusura:
8.21
0.39
+4.99%
Immatics N V Borsa (IMTX) Ultime notizie
Immatics: Q3 Earnings Snapshot - Milford Mirror
Immatics N.V. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Immatics reports Q3 EPS (EUR 0.11) vs. (EUR 0.32) last year - TipRanks
Immatics (IMTX) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance
Immatics announces clinical data on TCER IMA402 targeting PRAME - TipRanks
Immatics sees cash runway into 2H27 - TipRanks
Immatics Announces Third Quarter 2024 Financial Results, - GlobeNewswire
T. Rowe Price Investment Management, Inc. Reduces Stake in Immatics NV - GuruFocus.com
Immatics (NASDAQ:IMTX) Reaches New 52-Week LowShould You Sell? - MarketBeat
When the Price of (IMTX) Talks, People Listen - Stock Traders Daily
Immatics N.V. Warrants (IMTXW) SEC Filing Summary - Quartzy
IMTX (Immatics NV) FCF Yield % : -4.41 (As of Nov. 11, 2024) - GuruFocus.com
Immatics Announces Multiple Presentations at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC) on TCR-T Therapy Candidates Targeting PRAME - 新浪香港
Immatics Unveils Promising TCR-T Therapy Developments - TipRanks
Immatics Announces Multiple Presentations at the 39th - GlobeNewswire
Wellington Management Group LLP Increases Stake in Immatics NV - GuruFocus.com
Piper Sandler Initiates Coverage of Immatics N.V. (IMTX) with Overweight Recommendation - MSN
Immatics (IMTX) Expected to Beat Earnings Estimates: Should You Buy? - Yahoo Finance
232,900 Shares in Immatics (NASDAQ:IMTX) Bought by abrdn plc - MarketBeat
Objective long/short (IMTX) Report - Stock Traders Daily
Short Interest in Immatics (NASDAQ:IMTX) Expands By 5.3% - MarketBeat
Shareholders in Immatics (NASDAQ:IMTX) have lost 35%, as stock drops 6.3% this past week - Simply Wall St
Immatics N.V. (NASDAQ:IMTX) is a favorite amongst institutional investors who own 50% - Yahoo Finance
Perceptive Advisors LLC Reduces Stake in Immatics NV - Yahoo Finance
Immatics N.V. Announces Major Share Offering - TipRanks
Market Update: Immatics N.V (IMTX) Sees Negative Movement, Closing at 9.30 - The Dwinnex
Immatics (NASDAQ:IMTX) Short Interest Update - MarketBeat
It makes sense and dollars to buy Immatics N.V (IMTX) stock - SETE News
206,920 Shares in Immatics (NASDAQ:IMTX) Bought by Cubist Systematic Strategies LLC - MarketBeat
Immatics: A Promising TCR Pipeline (NASDAQ:IMTX) - Seeking Alpha
Upstream catches aftermarket updraft, as Camp4 IPO gets muted reception - BioCentury
Immatics (NASDAQ:IMTX) Sees Large Volume IncreaseWhat's Next? - MarketBeat
A closer look at IMTX’s price-to-free cash flow ratio - US Post News
Ratio Analysis: Unpacking Immatics N.V (IMTX)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex
Immatics Advances IMA203 to Phase 3 Trial in Melanoma - Yahoo Finance
Immatics Announces Pricing of $150 Million Public Offering - StockTitan
Immatics Off To Phase III With IMA203 After Positive Melanoma Results - Scrip
Why Is Cancer-Focused Immatics Stock Trading Lower On Thursday? - AOL
IMTX: Riding the Market Waves of Growth and Decline in 2023 - The InvestChronicle
Immatics Announces Proposed $150 Million Public Offering - GlobeNewswire
Immatics (NASDAQ:IMTX) Shares Gap DownHere's What Happened - MarketBeat
Form 424B2 Immatics N.V. - StreetInsider.com
Immatics provides update on Phase 1b trial of ACTengine in melanoma - TipRanks
Form 6-K Immatics N.V. For: Oct 10 - StreetInsider.com
Immatics Announces Updated Phase 1b Clinical Data on - GlobeNewswire
Immatics Announces Updated Phase 1b Clinical Data on ACTengine® IMA203 TCR-T Targeting PRAME in Melanoma Patients and Provides Update on Upcoming SUPRAME Phase 3 Trial - StockTitan
Immatics N.V. (IMTX) Receives Buy Rating from Analysts - Insider Monkey
Immatics (NASDAQ:IMTX) Shares Gap UpHere's Why - MarketBeat
Immatics (NASDAQ:IMTX) Earns Overweight Rating from Analysts at Piper Sandler - MarketBeat
3.66%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Capitalizzazione:
|
Volume (24 ore):